Delivery Order SPE2DB24D1034-SPE2DB25FWBN7
Award Date
3/27/25
Potential Completion Date
3/28/25
Potential Value
$9.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award, valued at $4,226.33, is for the delivery of IBSRELA 50 MG TABLET medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is a Delivery Order valued at $10,091.76 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is with the Defense Logistics Agency (DLA), an agency within the Department of Defense, to provide the pharmaceutical product IBSRELA 50 MG TABLET UU 60S. The contract has an ultimate completion date of November 7, 2024 and utilizes a Firm Fixed Price pricing type. This award is not associated with a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $3,424.60. The contract is for the supply of IBSRELA 50 MG TABLET UU 60S, a pharmaceutical product. The contract has an ultimate completion date of June 4, 2025. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,814.04 Firm Fixed Price delivery order is for the supply of IBSRELA 50 MG TABLET medication to support military healthcare programs. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $17,788.58 for the provision of 4566976306 - IBSRELA 50 MG TABLET UU 60S. The award was issued by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of January 21, 2025. AmerisourceBergen Drug Corp is the prime contractor for this firm fixed-price contract and there is no set-aside designation. The company also holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $10,840.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, with a completion date of July 11, 2024. The contract is for the procurement of IBSRELA 50 MG TABLET UU 60S, a pharmaceutical product. This award is not associated with a set-aside designation, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $72,986.26 firm fixed-price contract is for the delivery of IBSRELA 50 MG TABLET UU 60S, a pharmaceutical product. The contract has a completion date of June 18, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ID of SPE2DB22D3004|SPE2DB24FPQ40 and a ceiling value of $3,390.39. It is a delivery order contract for the pharmaceutical product Ibsrela 50 mg tablet, with a firm fixed price pricing type and an ultimate completion date of March 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of IBSRELA 50 MG TABLET UU 60S. The contract, with a ceiling value of $6,486.85, is a delivery order type with firm fixed pricing. The period of performance is from the award date of October 11, 2024 through October 15, 2024. This contract award is not designated as a set-aside. AmerisourceBergen has a significant Indefinite...
This federal contract award, valued at $41,958.32, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of IBSRELA 50 MG TABLET, a pharmaceutical product, and has an ultimate completion date of July 8, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...